Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells

Journal of Cellular Biochemistry

Volumn 115, Issue 1, 2014, Pages 27-33

  Koromila, Theodora ^a   Baniwal, Sanjeev K ^a   Song, Yae S ^a   Martin, Anthony ^a   Xiong, Jian ^a   Frenkel, Baruch ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

GLUCOCORTICOID INDUCED OSTEOPOROSIS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION

Indexed keywords

ALKALINE PHOSPHATASE; COMPLEMENTARY DNA; DEXAMETHASONE; DOXYCYCLINE; GLUCOCORTICOID RECEPTOR; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; DNA SEQUENCE; ENZYME ACTIVITY; GENE LOCUS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; MESENCHYME CELL; OSTEOBLAST; OSTEOBLAST DIFFERENTIATION; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GLUCOCORTICOID-INDUCED OSTEOPOROSIS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION;

ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; GLUCOCORTICOIDS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; PLURIPOTENT STEM CELLS; RECEPTORS, GLUCOCORTICOID;

EID: 84887923310     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24646     Document Type: Article

References (28)

1. Banerjee C, McCabe LR, Choi JY, Hiebert SW, Stein JL, Stein GS, Lian JB,. 1997. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66: 1-8.
2. Baniwal SK, Khalid O, Sir D, Buchanan G, Coetzee GA, Frenkel B,. 2009. Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA. Mol Endocrinol 23: 1203-1214.
3. Baniwal SK, Shah PK, Shi Y, Haduong JH, Declerck YA, Gabet Y, Frenkel B,. 2012. Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells. Osteoporos Int 23: 1399-1413.
4. Baniwal SK, Little GH, Chimge NO, Frenkel B,. 2012. Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation. J Cell Physiol 227: 2276-2282.
5. Baschant U, Lane NE, Tuckermann J,. 2012. The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol 8: 645-655.
6. Brennan-Speranza TC, Henneicke H, Gasparini SJ, Blankenstein KI, Heinevetter U, Cogger VC, Svistounov D, Zhang Y, Cooney GJ, Buttgereit F, Dunstan CR, Gundberg C, Zhou H, Seibel MJ,. 2012. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest 122: 4172-4189.
7. Canalis E,. 1984. Effect of cortisol on periosteal and nonperiosteal collagen and DNA synthesis in cultured rat calvariae. Calcif Tissue Int 36: 158-166.
8. Canalis E, Mazziotti G, Giustina A, Bilezikian JP,. 2007. Glucocorticoid-induced osteoporosis: Pathophysiology and therapy. Osteoporos Int 18: 1319-1328.
9. Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella M,. 1998. Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 273: 4892-4896.
10. Chimge NO, Baniwal SK, Luo J, Coetzee S, Khalid O, Berman BP, Tripathy D, Ellis MJ, Frenkel B,. 2012. Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: In vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness. Clin Cancer Res 18: 901-911.
11. Ducy P, Karsenty G,. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15: 1858-1869.
12. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G,. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
13. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G,. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13: 1025-1036.
14. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, Oei L, Albagha OM, Amin N, Kemp JP, Koller DL, Li G, Liu CT, Minster RL, Moayyeri A, Vandenput L, Willner D, Xiao SM, Yerges-Armstrong LM, Zheng HF, Alonso N, Eriksson J, Kammerer CM, Kaptoge SK, Leo PJ, Thorleifsson G, Wilson SG, Wilson JF, Aalto V, Alen M, Aragaki AK, Aspelund T, Center JR, Dailiana Z, Duggan DJ, Garcia M, Garcia-Giralt N, Giroux S, Hallmans G, Hocking LJ, Husted LB, Jameson KA, Khusainova R, Kim GS, Kooperberg C, Koromila T, Kruk M, Laaksonen M, Lacroix AZ, Lee SH, Leung PC, Lewis JR, Masi L, Mencej-Bedrac S, Nguyen TV, Nogues X, Patel MS, Prezelj J, Rose LM, Scollen S, Siggeirsdottir K, Smith AV, Svensson O, Trompet S, Trummer O, van Schoor NM, Woo J, Zhu K, Balcells S, Brandi ML, Buckley BM, Cheng S, Christiansen C, Cooper C, Dedoussis G, Ford I, Frost M, Goltzman D, Gonzalez-Macias J, Kahonen M, Karlsson M, Khusnutdinova E, Koh JM, Kollia P, Langdahl BL, Leslie WD, Lips P, Ljunggren O, Lorenc RS, Marc J, Mellstrom D, Obermayer-Pietsch B, Olmos JM, Pettersson-Kymmer U, Reid DM, Riancho JA, Ridker PM, Rousseau F, Slagboom PE, Tang NL, et al. 2012. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44: 491-501.
15. Frenkel B, Hong A, Baniwal SK, Coetzee GA, Ohlsson C, Khalid O, Gabet Y,. 2010. Regulation of adult bone turnover by sex steroids. J Cell Physiol 224: 305-310.
16. Kawate H, Wu Y, Ohnaka K, Takayanagi R,. 2007. Mutual transactivational repression of Runx2 and the androgen receptor by an impairment of their normal compartmentalization. J Steroid Biochem Mol Biol 105: 46-56.
17. Khalid O, Baniwal SK, Purcell DJ, Leclerc N, Gabet Y, Stallcup MR, Coetzee GA, Frenkel B,. 2008. Modulation of Runx2 activity by estrogen receptor-alpha: Implications for osteoporosis and breast cancer. Endocrinology 149: 5984-5995.
18. Komori T,. 2011. Signaling networks in RUNX2-dependent bone development. J Cell Biochem 112: 750-755.
19. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T,. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
20. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G,. 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469.
21. McCarthy TL, Chang WZ, Liu Y, Centrella M,. 2003. Runx2 integrates estrogen activity in osteoblasts. J Biol Chem 278: 43121-43129.
22. Ning YM, Robins DM,. 1999. AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. J Biol Chem 274: 30624-30630.
23. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ,. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
24. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M,. 2004. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24: 8847- 8861.
25. Pereira RM, Delany AM, Canalis E,. 2001. Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone 28: 484- 490.
26. Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B,. 2000. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cdk2 from E2F4-p130 complexes. J Biol Chem 275: 19992-20001.
27. Weinstein RS,. 2012. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am 41: 595-611.
28. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC,. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282.